Today’s guidance explains that POs can ensure access to Part D drugs by relaxing “refill-too-soon” edits & providing maximum extended day supply & waiving prior authorization requirements at any time that they otherwise would apply to drugs used to treat or prevent #COVID19.
Researchers have found that the time between cases in a chain of #COVID19 transmission is less than a week and that more than 10% of patients were infected by an asymptomatic person.
Learn more: https://t.co/jj4OflEZ5I
Trying to navigate all the information about #COVID19 can be stressful and can affect your body and mind. Cigna has put together resources to make it easier. Click here to learn more about how you can stay healthy and what to do if you feel ill. #CignaNews https://t.co/kZyMSyFkR7
New research: The virus that causes #COVID19 can be stable for days on surfaces, depending on the material. Study in @NEJM detects SARS-CoV-2 up to to 4 hours on copper, 24 hours on cardboard and 2-3 days on plastic & stainless steel: https://t.co/hrdUWc5lCN
Researchers at @KPWaResearch are evaluating an investigational vaccine against #COVID19 in a Phase 1 clinical trial in Seattle: https://t.co/PpFRAexQT8
Cleaning up with disinfecting products this week? Remember to never mix household bleach with ammonia or any other cleanser--it can create dangerous, toxic fumes! More important info from @CDCgov: https://t.co/ffDi0nbArR #NPPW20#PreventPoison#PoisonHelp
Reminder: Market Analytics All-Team meeting this Wednesday, 9/12 @ 2pm CST/3pm EST. For those in NJ, we’ll meet in the Cube. Among the topics will be recognitions, announcements and Cigna integration. Looking forward to seeing everyone. Please come prepared with your questions.